Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cytokinetics (CYTK)
NASDAQ:CYTK
Holding CYTK?
Track your performance easily
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Dec 16, 2024 | Wendall Wierenga Director | xxxxxxxxxxxxx | $36069 |
| Dec 12, 2024 | John Henderson Director | xxxxxxxxxxxxx | $89748 |
| Dec 10, 2024 | Fady Ibraham Malik Evp Research & Development | xxxxxxxxxxxxx | $369639 |
| Dec 02, 2024 | Robert Blum President & Ceo,director | xxxxxxxxxxxxx | $253800 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2024 | xxxxxxxxxxxxx | $465960 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $680275 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $715704 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $1280400 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 11,308,358 | Institution | 9.58% | 552,639,455 | |
| 10,318,599 | Institution | 8.74% | 504,269,933 | |
| 10,086,951 | Institution | 8.55% | 492,949,295 | |
| 4,369,007 | Institution | 3.70% | 213,513,372 | |
| 4,067,922 | Institution | 3.45% | 198,799,348 | |
| 2,252,713 | Institution | 1.91% | 110,090,084 | |
| 1,994,600 | Institution | 1.69% | 97,476,102 | |
| 1,821,115 | Institution | 1.54% | 88,997,890 | |
| 1,598,152 | Institution | 1.35% | 78,101,688 | |
| 1,596,371 | Institution | 1.35% | 78,014,651 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 10,086,951 | Institution | 8.55% | 492,949,295 | |
| 4,067,922 | Institution | 3.45% | 198,799,348 | |
| 2,252,713 | Institution | 1.91% | 110,090,084 | |
| 1,994,600 | Institution | 1.69% | 97,476,102 | |
| 1,821,115 | Institution | 1.54% | 88,997,890 | |
| 1,598,152 | Institution | 1.35% | 78,101,688 | |
| 1,596,371 | Institution | 1.35% | 78,014,651 | |
| 1,458,239 | Institution | 1.24% | 71,264,140 | |
| 1,297,216 | Institution | 1.10% | 63,394,946 | |
| 1,249,958 | Institution | 1.06% | 61,085,447 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,732,980 | Institution | 3.16% | 190,381,980 | |
| 3,797,117 | Institution | 3.22% | 185,565,108 | |
| 3,273,363 | Institution | 2.77% | 159,969,250 | |
| 2,950,999 | Institution | 2.50% | 150,500,949 | |
| 2,183,093 | Institution | 1.85% | 102,037,767 | |
| 1,755,460 | Institution | 1.49% | 89,528,460 | |
| 1,622,191 | Institution | 1.37% | 82,731,741 | |
| 1,018,268 | Institution | 0.86% | 49,762,757 | |
| 970,637 | Institution | 0.82% | 47,435,030 | |
| 775,712 | Institution | 0.66% | 37,909,045 |
FAQ
Who Owns Cytokinetics (CYTK)?
Currently, no data Available
What percentage of Cytokinetics (CYTK) stock is held by institutional investors?
Currently, no data Available
What percentage of Cytokinetics (CYTK) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Cytokinetics (CYTK)?
Vanguard owns the most shares of Cytokinetics (CYTK).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.